Companies engaged in science and discovery research may not have resources to evaluate disease categories and therapeutic indications that suit their targets and scientific approach. Bioscience Valuation’s indication scoping services include, but are not limited to,

• Investigation of the relevance of the target and (assumed) mechanism of action for therapeutic indications,
• assessment of medical need,
• creation of target product profiles,
• current and future disease prevalence/incidence in major markets and beyond,
• product pricing, market access and high level pharmacoeconomics,
• analysis of the competitive landscape (marketed drugs and R&D pipelines),
• determination of potential patient (market) shares, peak sales potential, contribution to the assessment of target validation status,
• analysis of development plans including costs as well as development risks,
• program valuation,
• other related services including primary market research.